Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
HeLa and HT-29 cells) treatment significantly increases the cytotoxicity of DNA damage
NVP-231 synergistically increased ceramide levels and reduced cell growth
InChi: InChI=1S/C25H22ClN5O2S/c1-13-14(2)34-25-22(13)23(16-4-6-17(26)7-5-16)28-20(24-30-29-15(3)31(24)25)12-21(33)27-18-8-10-19(32)11-9-18/h4-11
InChi: InChI=1S/C29H32N4O5S2/c1-5-30-29(35)32-40(36
51(6):407-12
Ziprasidone - CAS# 146939-27-7 dacaterol maleate HeLa and HT-29 cells) treatmentZiprazidone is approved for the treatment of schizophrenia, and acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate. The mechanism of action of ziprasidone, as with other drugs having efficacy in schizophrenia, is unknown. However, it has been proposed that this drug's efficacy in schizophrenia